Universe Pharmaceuticals (UPC) Enterprise Value: 2019-2024
Historic Enterprise Value for Universe Pharmaceuticals (UPC) over the last 6 years, with Sep 2024 value amounting to -$30.0 million.
- Universe Pharmaceuticals' Enterprise Value fell 3917.49% to -$30.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$63.5 million, marking a year-over-year decrease of 6.64%. This contributed to the annual value of -$30.0 million for FY2024, which is 3917.49% down from last year.
- Latest data reveals that Universe Pharmaceuticals reported Enterprise Value of -$30.0 million as of FY2024, which was down 3,917.49% from $785,488 recorded in FY2023.
- Over the past 5 years, Universe Pharmaceuticals' Enterprise Value peaked at $30.1 million during FY2021, and registered a low of -$30.0 million during FY2024.
- Moreover, its 3-year median value for Enterprise Value was -$6.6 million (2022), whereas its average is -$11.9 million.
- Its Enterprise Value has fluctuated over the past 5 years, first spiked by 398.93% in 2021, then slumped by 3,917.49% in 2024.
- Universe Pharmaceuticals' Enterprise Value (Yearly) stood at -$10.1 million in 2020, then skyrocketed by 398.93% to $30.1 million in 2021, then crashed by 121.86% to -$6.6 million in 2022, then soared by 111.95% to $785,488 in 2023, then plummeted by 3,917.49% to -$30.0 million in 2024.